News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
872,867 Results
Type
Article (88157)
Company Profile (825)
Press Release (783866)
Multimedia
Podcasts (206)
Webinars (30)
Section
Business (233342)
Career Advice (4152)
Deals (39895)
Drug Delivery (155)
Drug Development (91473)
Employer Resources (205)
FDA (18425)
Job Trends (17439)
News (398103)
Policy (39990)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3023)
Academic (2)
Accelerated approval (38)
Adcomms (36)
Allergies (161)
Alliances (56982)
ALS (189)
Alzheimer's disease (1824)
Antibody-drug conjugate (ADC) (371)
Approvals (18623)
Artificial intelligence (671)
Autoimmune disease (188)
Automation (46)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (212)
Biotechnology (490)
Bladder cancer (171)
Brain cancer (68)
Breast cancer (692)
Cancer (5286)
Cardiovascular disease (468)
Career advice (3577)
Career pathing (43)
CAR-T (317)
CDC (66)
Celiac Disease (2)
Cell therapy (870)
Cervical cancer (39)
Clinical research (77342)
Collaboration (1931)
Company closure (5)
Compensation (1221)
Complete response letters (79)
COVID-19 (3002)
CRISPR (106)
C-suite (953)
Cystic fibrosis (155)
Data (6600)
Decentralized trials (2)
Denatured (76)
Depression (160)
Diabetes (553)
Diagnostics (7311)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (328)
Drug pricing (230)
Drug shortages (36)
Duchenne muscular dystrophy (255)
Earnings (100648)
Editorial (69)
Employer branding (25)
Employer resources (174)
Events (135733)
Executive appointments (1067)
FDA (21771)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1629)
Gene editing (229)
Generative AI (71)
Gene therapy (708)
GLP-1 (1164)
Government (5475)
Grass and pollen (8)
Guidances (389)
Healthcare (20978)
HIV (76)
Huntington's disease (53)
IgA nephropathy (89)
Immunology and inflammation (308)
Immuno-oncology (74)
Indications (126)
Infectious disease (3319)
Inflammatory bowel disease (216)
Inflation Reduction Act (17)
Influenza (133)
Intellectual property (268)
Interviews (817)
IPO (17969)
IRA (61)
Job creations (5202)
Job search strategy (2867)
JPM (72)
Kidney cancer (20)
Labor market (98)
Layoffs (662)
Leadership (43)
Legal (10166)
Liver cancer (100)
Longevity (19)
Lung cancer (712)
Lymphoma (394)
Machine learning (46)
Management (66)
Manufacturing (914)
MASH (180)
Medical device (15086)
Medtech (15150)
Mergers & acquisitions (23028)
Metabolic disorders (1467)
mRNA (200)
Multiple sclerosis (176)
NASH (23)
Neurodegenerative disease (380)
Neuropsychiatric disorders (108)
Neuroscience (3231)
Neurotech (1)
NextGen: Class of 2026 (7710)
Non-profit (5120)
Now hiring (70)
Obesity (716)
Opinion (347)
Ovarian cancer (173)
Pain (226)
Pancreatic cancer (249)
Parkinson's disease (315)
Partnered (39)
Patents (543)
Patient recruitment (544)
Peanut (64)
People (67122)
Pharmaceutical (145)
Pharmacy benefit managers (34)
Phase 1 (23900)
Phase 2 (33560)
Phase 3 (25276)
Pipeline (5907)
Policy (354)
Postmarket research (3554)
Preclinical (10721)
Press Release (72)
Prostate cancer (267)
Psychedelics (60)
Radiopharmaceuticals (316)
Rare diseases (992)
Real estate (7444)
Recruiting (81)
Regulatory (29302)
Reports (69)
Research institute (2740)
Resumes & cover letters (653)
Rett syndrome (29)
RNA editing (21)
RSV (90)
Schizophrenia (165)
Series A (273)
Series B (206)
Service/supplier (30)
Sickle cell disease (110)
Special edition (28)
Spinal muscular atrophy (178)
Sponsored (49)
Startups (4339)
State (2)
Stomach cancer (21)
Supply chain (116)
Tariffs (101)
The Weekly (128)
Vaccines (1188)
Venture capital (101)
Weight loss (493)
Women's health (103)
Worklife (23)
Date
Today (235)
Last 7 days (960)
Last 30 days (3069)
Last 365 days (32903)
2026 (5180)
2025 (33228)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (95)
Alaska (7)
Arizona (354)
Arkansas (15)
Asia (51674)
Australia (9078)
California (12104)
Canada (3447)
China (1221)
Colorado (510)
Connecticut (526)
Delaware (360)
Europe (118875)
Florida (1797)
Georgia (390)
Hawaii (4)
Idaho (68)
Illinois (1009)
India (79)
Indiana (569)
Iowa (24)
Japan (461)
Kansas (135)
Kentucky (46)
Louisiana (31)
Maine (84)
Maryland (1506)
Massachusetts (8872)
Michigan (377)
Minnesota (681)
Mississippi (6)
Missouri (144)
Montana (36)
Nebraska (30)
Nevada (132)
New Hampshire (88)
New Jersey (3245)
New Mexico (33)
New York (3187)
North Carolina (1671)
North Dakota (10)
Northern California (5855)
Ohio (375)
Oklahoma (23)
Oregon (55)
Pennsylvania (2412)
Puerto Rico (25)
Rhode Island (52)
South America (1665)
South Carolina (70)
South Dakota (1)
Southern California (4680)
Tennessee (185)
Texas (1903)
United States (43540)
Utah (367)
Vermont (1)
Virginia (306)
Washington D.C. (88)
Washington State (1005)
West Virginia (4)
Wisconsin (138)
Wyoming (2)
There are 872,867 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Insights
ALS Advances Unite Patients and Pharma on Novel Targets, Biomarker Breakthroughs
In this episode of Denatured, you’ll be listening to Indu Navar, CEO and founder of EverythingALS and Dr. Olga Uspenskaya, chief medical officer at VectorY Therapeutics. We’ll be speaking about patient-pharma collaborations accelerating trials and hope, advances in ALS biology understanding and biomarker-driven endpoints.
February 26, 2026
·
1 min read
·
Jennifer Smith-Parker
Press Releases
Amylyx Pharmaceuticals to Participate in Upcoming March 2026 Investor Conferences
February 26, 2026
·
1 min read
Press Releases
Evvy Unveils Data-Driven Subtypes of Bacterial Vaginosis
February 26, 2026
·
4 min read
Press Releases
A2 Biotherapeutics Doses First Patient in EVEREST-2 Study with A2B543, a Logic-Gated CAR T Cell Therapy Enhanced with a Membrane-Tethered IL-12 Booster
February 26, 2026
·
5 min read
Press Releases
ValGenesis to Join Industry Peers at 2026 ISPE San Francisco Vendor Night
February 26, 2026
·
1 min read
Press Releases
insitro Appoints Joe Hand as Chief People Officer to Advance Talent Strategy for Next Stage of Development
February 26, 2026
·
3 min read
Press Releases
Verist Inc. Announces Relationship with Basil Systems to Strengthen Life Sciences Offering
February 26, 2026
·
3 min read
Press Releases
Quanterix to Participate in Upcoming March 2026 Investor Conferences
February 26, 2026
·
1 min read
Press Releases
Thermo Fisher Scientific Introduces New Laboratory Developed Test to Help Transplant Patients Receive the Right Dose of Critical Anti-Rejection Medication Sooner
February 26, 2026
·
3 min read
Press Releases
Sarepta Therapeutics to Present New Long-Term and Safety Data Across Gene Therapy and Exon-Skipping Programs at 2026 Muscular Dystrophy Association Clinical & Scientific Congress
February 26, 2026
·
6 min read
1 of 87,287
Next
